MARKET

RGEN

RGEN

Repligen
NASDAQ
126.92
-3.48
-2.67%
Opening 15:04 05/07 EDT
OPEN
131.52
PREV CLOSE
130.40
HIGH
133.18
LOW
125.31
VOLUME
955.15K
TURNOVER
--
52 WEEK HIGH
182.52
52 WEEK LOW
102.97
MARKET CAP
7.13B
P/E (TTM)
-279.5595
1D
5D
1M
3M
1Y
5Y
1D
Repligen Corporation to Present at Upcoming May Investor Conferences
Barchart · 12h ago
Repligen’s Strategic Growth and Resilience Drive Buy Rating with $180 Price Target
TipRanks · 2d ago
Weekly Report: what happened at RGEN last week (0428-0502)?
Weekly Report · 2d ago
Repligen’s Strong Market Position and Growth Potential Justify Buy Rating Amid Minimal Tariff Exposure
TipRanks · 6d ago
Deep Dive Into Repligen Stock: Analyst Perspectives (8 Ratings)
Benzinga · 6d ago
Repligen Is Maintained at Outperform by RBC Capital
Dow Jones · 04/30 16:16
Repligen Price Target Cut to $189.00/Share From $202.00 by RBC Capital
Dow Jones · 04/30 16:16
RBC Capital Maintains Outperform on Repligen, Lowers Price Target to $189
Benzinga · 04/30 16:06
More
About RGEN
More
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.
Recently
Symbol
Price
%Change

Webull offers Repligen Corp stock information, including NASDAQ: RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.